Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 5.16% vs 7.90% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -1.42% vs 34.91% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 3.20% vs 11.11% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 5.27% vs -14.92% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of AstraZeneca PLC With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -2.67% vs 3.49% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.16% vs 7.90% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 30.57% vs -6.83% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.42% vs 34.91% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 21.75% vs -11.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.20% vs 11.11% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -19.84% vs 13.08% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.27% vs -14.92% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






